ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia

被引:14
作者
Hoelzer, D. [1 ]
Bassan, R. [2 ,3 ]
Boissel, N. [4 ]
Roddie, C. [5 ]
Ribera, J. M. [6 ]
Jerkeman, M. [7 ,8 ]
机构
[1] ONKOL Frankfurt Museumsufer, Frankfurt, Germany
[2] Osped Angelo, Hematol Unit, Mestre Venezia, Italy
[3] Osped SS Giovanni & Paolo, Mestre Venezia, Italy
[4] Univ Paris Cite, St Louis Hosp, AP HP, Hematol Dept,Inst Rech St Louis, Paris, France
[5] UCL Canc Inst, Res Dept Haematol, London, England
[6] Univ Autonoma Barcelona, Jose Carreras Res Inst, Clin Hematol Dept, ICO Hosp Germans Trias & Pujol, Barcelona, Spain
[7] Skane Univ Hosp, Dept Oncol, Lund, Sweden
[8] Lund Univ, Lund, Sweden
关键词
acute lymphoblastic leukaemia; ESMO Clinical Practice Guideline update; immunotherapy; treatment; tyrosine kinase inhibitor; CHIMERIC ANTIGEN RECEPTOR; CAR T-CELLS; MINIMAL RESIDUAL DISEASE; TERM-FOLLOW-UP; ADULT PATIENTS; HYPER-CVAD; YOUNG-ADULTS; SINGLE-ARM; INTENSITY CHEMOTHERAPY; MOLECULAR RESPONSE;
D O I
10.1016/j.annonc.2023.09.3112
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:15 / 28
页数:14
相关论文
共 109 条
[1]   Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia [J].
Advani, Anjali S. ;
Moseley, Anna ;
O'Dwyer, Kristen M. ;
Wood, Brent L. ;
Park, Jae ;
Wieduwilt, Matthew ;
Jeyakumar, Deepa ;
Yaghmour, George ;
Atallah, Ehab L. ;
Gerds, Aaron T. ;
O'Brien, Susan M. ;
Liesveld, Jane L. ;
Othus, Megan ;
Litzow, Mark ;
Stone, Richard M. ;
Sharon, Elad ;
Erba, Harry P. .
BLOOD ADVANCES, 2023, 7 (07) :1279-1285
[2]   SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia [J].
Advani, Anjali S. ;
Moseley, Anna ;
O'Dwyer, Kristen M. ;
Wood, Brent L. ;
Fang, Min ;
Wieduwilt, Matthew J. ;
Aldoss, Ibrahim ;
Park, Jae H. ;
Klisovic, Rebecca B. ;
Baer, Maria R. ;
Stock, Wendy ;
Bhave, Rupali R. ;
Othus, Megan ;
Harvey, Richard C. ;
Willman, Cheryl L. ;
Litzow, Mark R. ;
Stone, Richard M. ;
Sharon, Elad ;
Erba, Harry P. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) :1574-+
[3]   Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL [J].
Aldoss, Ibrahim ;
Khaled, Samer K. ;
Wang, Xiuli ;
Palmer, Joycelynne ;
Wang, Yan ;
Wagner, Jamie R. ;
Clark, Mary C. ;
Simpson, Jennifer ;
Paul, Jinny ;
Vyas, Vibhuti ;
Chien, Sheng-Hsuan ;
Stein, Anthony ;
Pullarkat, Vinod ;
Salhotra, Amandeep ;
Al Malki, Monzr M. ;
Aribi, Ahmed ;
Sandhu, Karamjeet ;
Thomas, Sandra H. ;
Budde, Lihua E. ;
Marcucci, Guido ;
Brown, Christine E. ;
Forman, Stephen J. .
CLINICAL CANCER RESEARCH, 2023, 29 (04) :742-753
[4]   Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults [J].
Amrein, Philip ;
Ballen, Karen ;
Stevenson, Kristen ;
Brunner, Andrew ;
Hobbs, Gabriela ;
Hock, Hanno ;
McAfee, Steven ;
Moran, Jenna ;
Bergeron, Meghan ;
Foster, Julia ;
Bertoli, Christina ;
McGreggor, Kristin ;
Macrea, Molly ;
Burke, Meghan ;
Behnam, Tanya ;
Som, Tina ;
Ramos, Aura ;
Vartanian, Megan ;
Story, Jennifer Lombardi ;
Connolly, Christine ;
Blonquist, Traci ;
Neuberg, Donna ;
Fathi, Amir .
LEUKEMIA & LYMPHOMA, 2022, 63 (06) :1428-1435
[5]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[6]   Tumor regression in cancer patients by very low doses of a T cell-engaging antibody [J].
Bargou, Ralf ;
Leo, Eugen ;
Zugmaier, Gerhard ;
Klinger, Matthias ;
Goebeler, Mariele ;
Knop, Stefan ;
Noppeney, Richard ;
Viardot, Andreas ;
Hess, Georg ;
Schuler, Martin ;
Einsele, Hermann ;
Brandl, Christian ;
Wolf, Andreas ;
Kirchinger, Petra ;
Klappers, Petra ;
Schmidt, Margit ;
Riethmueller, Gert ;
Reinhardt, Carsten ;
Baeuerle, Patrick A. ;
Kufer, Peter .
SCIENCE, 2008, 321 (5891) :974-977
[7]  
Bassan R, 2021, EHA Libr, pS114
[8]   New Approaches to the Management of Adult Acute Lymphoblastic Leukemia [J].
Bassan, Renato ;
Bourquin, Jean-Pierre ;
DeAngelo, Daniel J. ;
Chiaretti, Sabina .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (35) :3504-+
[9]   Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients [J].
Biasco, Luca ;
Izotova, Natalia ;
Rivat, Christine ;
Ghorashian, Sara ;
Richardson, Rachel ;
Guvenel, Aleks ;
Hough, Rachael ;
Wynn, Robert ;
Popova, Bilyana ;
Lopes, Andre ;
Pule, Martin ;
Thrasher, Adrian J. ;
Amrolia, Persis J. .
NATURE CANCER, 2021, 2 (06) :629-642
[10]   Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2 [J].
Boissel, Nicolas ;
Huguet, Francoise ;
Graux, Carlos ;
Hicheri, Yosr ;
Chevallier, Patrice ;
KIM, Rathana ;
Balsat, Marie ;
Leguay, Thibaut ;
Hunault, Mathilde ;
Maury, Sébastien ;
Thiebaut-Bertrand, Anne ;
Escoffre-Barbe, Martine ;
Cluzeau, Thomas ;
Villate, Alban ;
Pasquier, Florence ;
Farnault, Laure ;
Van Obbergh, Florence ;
Rousselot, Philippe ;
Chalandon, Yves ;
Delabesse, Eric ;
Pastoret, Cedric ;
Clappier, Emmanuelle ;
Lheritier, Veronique ;
Dombret, Herve .
BLOOD, 2021, 138